The Orthopaedic Implant Company

The Orthopaedic Implant Company (OIC) is a US-based manufacturer and distributor of orthopedic implants focused on trauma, fracture fixation, and sports medicine applications. The company specializes in value-based orthopedic implant systems designed to reduce healthcare costs without compromising clinical outcomes. Product portfolio includes intramedullary nails (tibial, femoral, metacarpal), plating systems (plates and screws, mini-fragment plates, wrist fracture plates), external fixation systems, cannulated screws, ankle fixation implants (including Flex-Fix™ syndesmotic repair system), hand and wrist implants, hip fracture implants, and sports medicine suture anchors. OIC markets its implants directly to orthopedic surgeons, hospital systems, trauma centers, and integrated delivery networks, emphasizing transparent pricing and clinical equivalence to premium competitors. The company holds FDA 510(k) clearances for multiple product lines and maintains ISO 13485:2016 certification. OIC was acquired by Zeda in February 2024 and has expanded internationally with partnerships for manufacturing and distribution in Asia, Central America, and South America, including a strategic alliance to launch a 3D printing hub for orthopedic implants in India. The company operates from Reno, Nevada, and has established itself as a disruptor in the orthopedic implant market through affordability and value-based care initiatives.